CannTrust Holdings Inc.

+$0.00 (+0.0%)
Closing price April 14, 2020
Investors of Aurora Cannabis, like investors everywhere, are an impatient lot. Wall Street expects profits, and none of these marijuana companies is anywhere near profitability.
Cannabis stocks took a beating Friday after an analyst's comment that supplies would remain tight this year. But that's not all that's wrong in the pot sector.
As the bad news piled up for CannTrust last year, the rest of the cannabis industry also imploded. What to expect from CannTrust in 2020 is a glass either half-empty or half-full.
For those with a long-term horizon, now may be a good time to buy some shares in cannabis stocks, put them in your account and be patient. Merrill Lynch has five pot stocks rated Buy, and all have...
The top analyst upgrades, downgrades and initiations seen on Monday included American Express, Apple, Applied Materials, Best Buy, Crowdstrike, F5 Networks, NetApp and Verizon Communications.
Merrill Lynch has coverage on the marijuana industry, and when a major Wall Street firm like this one starts and maintains coverage, it pretty much legitimizes things for good.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec and Tesla.
Marijuana producer CannTrustintends to price more than 36 million shares to result in a secondary offering valued up to roughly $230 million.
Initial public offerings and significant investment by established firms raised the valuations of several companies in the marijuana-related sector. Here are the 10 largest firms at the end of 2018.